Table 1.

Demographic and clinical characteristics of participants who likely have chronic pain and those who likely do not have chronic pain

Participant characteristicsChronic pain (n = 14)
N (%)
No chronic pain (n = 19)
N (%)
P value
Age (median, IQR) 36 (23-36) 29 (30.5-44) .042  
Sex, female 7 (50.0) 8 (42.1) .65  
Genotype  
HbSS 7 (50.0) 14 (73.6) .364  
HbSC 6 (42.9) 4 (21.1)  
HbSβ+ 1 (7.1) 1 (5.3)  
Hydroxyurea use 9 (64.3) 17 (89.4) .106  
Taking at least 1 type of opioid 12 (85.7) 13 (68.4) .416  
Taking acetaminophen, ibuprofen, or naproxen 7 (50.0) 14 (73.7) .459  
Treated for pain in the hospital or clinic in the past 3 months 11 (78.6) 7 (36.8) .017  
Pain frequency in a typical month 
No pain at all 3 (15.8) N/A 
1-2 times a month 9 (47.4)  
1-2 times a week 5 (26.3)  
More than 10 times a month 2 (14.3) 1 (5.3)  
3-4 times a week 4 (28.6)  
5-6 times a week 1 (5.3)  
Everyday 8 (57.1)  
Participant characteristicsChronic pain (n = 14)
N (%)
No chronic pain (n = 19)
N (%)
P value
Age (median, IQR) 36 (23-36) 29 (30.5-44) .042  
Sex, female 7 (50.0) 8 (42.1) .65  
Genotype  
HbSS 7 (50.0) 14 (73.6) .364  
HbSC 6 (42.9) 4 (21.1)  
HbSβ+ 1 (7.1) 1 (5.3)  
Hydroxyurea use 9 (64.3) 17 (89.4) .106  
Taking at least 1 type of opioid 12 (85.7) 13 (68.4) .416  
Taking acetaminophen, ibuprofen, or naproxen 7 (50.0) 14 (73.7) .459  
Treated for pain in the hospital or clinic in the past 3 months 11 (78.6) 7 (36.8) .017  
Pain frequency in a typical month 
No pain at all 3 (15.8) N/A 
1-2 times a month 9 (47.4)  
1-2 times a week 5 (26.3)  
More than 10 times a month 2 (14.3) 1 (5.3)  
3-4 times a week 4 (28.6)  
5-6 times a week 1 (5.3)  
Everyday 8 (57.1)  

Significant P values are shown in bold.

Mann-Whitney U test.

χ2 test or Fisher exact test.

or Create an Account

Close Modal
Close Modal